Issue 55, 2016, Issue in Progress

Four new meridamycin congeners from Streptomyces sp. SR107

Abstract

Meridamycin and its naturally occurring analog normeridamycin are non-immunosuppressive macrocyclic polyketides with potent neuroprotective activity in dopaminergic neurons. Although the biosynthetic gene cluster of meridamycin has been cloned and therefore generated the analogue, C36-keto-meridamycin, the diversity of this type of unique macrolide is still undiscovered. In this paper, four meridamycin congeners, namely meridamycin A (2), meridamycin B (3), meridamycin C (4) and meridamycin D (5), together with meridamycin (1), were isolated from the agar fermentation of the strain Streptomyces sp. SR107. The structures of these compounds were elucidated on the basis of 1D-, 2D-NMR, and HRESIMS data analysis. The antibacterial activities of compounds 1–5 were also evaluated.

Graphical abstract: Four new meridamycin congeners from Streptomyces sp. SR107

Supplementary files

Article information

Article type
Paper
Submitted
15 Apr 2016
Accepted
13 May 2016
First published
16 May 2016

RSC Adv., 2016,6, 49792-49796

Four new meridamycin congeners from Streptomyces sp. SR107

M. Liu, C. Lu and Y. Shen, RSC Adv., 2016, 6, 49792 DOI: 10.1039/C6RA09772C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements